Iverheal 12 mg is an antiparasitic medication that exerts its therapeutic effects by targeting the nervous system of parasites. Originally developed for veterinary use, it has found application in treating certain human parasitic infections. Ivermectin works by binding to specific receptors in nerve and muscle cells of parasites, leading to an increase in the permeability of cell membranes. This disrupts the normal functioning of neurotransmitters, particularly gamma-aminobutyric acid (GABA), which plays a crucial role in inhibiting nerve impulses. As a result, the parasites experience paralysis and eventual death. It's important to note that while some studies have explored the potential use of ivermectin in the context of viral infections, such as COVID-19, more research is needed to establish its efficacy and safety for these purposes.